CD4+ CD25+ regulatory T cells approach the clinic

By Edinger M.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 655-656

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD4⁺⁺ CD25⁺⁺ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

By Shim Jua   Lee Eun-So   Park Sun   Bang Dongsik   Sohn Seonghyang  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 835-847

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

By Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 698-710

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia

By Kobbe G   Fenk R   Neumann F   Bernhardt A   Steidl U   Kondakci M   Graef T   Aivado M   Vaupel M   Huenerlituerkoglu A-N   Kronenwett R   Pape H   Hildebrand B   Germing U   Haas R  

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 533-542

Ashgate Publishing Ltd

Access to resources Recommend Favorite